Fundraising Fox

Celsense

Pittsburgh, US · Delaware corporation

celsense.com ↗
Biotech

Founders & leadership

CF
Charles F. O'Hanlon, IIIExecutive
LM
Lourdes M. CastellanosExecutive
ET
Eric T. AhrensNamed on SEC filing
TR
T. Ronald CasperNamed on SEC filing
RB
Ronald B. HerbermanNamed on SEC filing
ET
Eric T. AhernsNamed on SEC filing
KS
Kevin S. McClatchyNamed on SEC filing

Board

LG
L. Gerald TarantinoBoard director
DP
Daniel P. Gallagher, Jr.Board director
GT
Gregory T. HebrankBoard director
TP
Thomas Petzinger, Jr.Board director
PL
Paul L. KornblithBoard director

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 6 of 7 rounds · 2012–2020

▶$500KofferedFeb 2020 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lourdes M. CastellanosExecutive Officer
  • L. Gerald TarantinoDirector
  • Paul L. KornblithDirector
  • Thomas Petzinger, Jr.Director
  • Jeffrey S. FriedmanDirector
  • Charles F. O'Hanlon, IIIExecutive Officer, Director
  • Gregory T. HebrankDirector
Offering amount
$500K
Minimum investment
$5K
Proceeds to insiders
$150K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$125KraisedMay 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles F. O'Hanlon, IIIExecutive Officer, Director
  • Gregory T. HebrankDirector
  • Jeffrey S. FriedmanDirector
  • Paul L. KornblithDirector
  • Thomas Petzinger, Jr.Director
  • Lourdes M. CastellanosExecutive Officer
  • L. Gerald TarantinoDirector
Offering amount
$800K
Amount sold
$125K
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$710KraisedApr 2017 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Petzinger, Jr.Director
  • Jeffrey S. FriedmanDirector
  • Charles F. O'Hanlon, IIIExecutive Officer, Director
  • Lourdes M. CastellanosExecutive Officer
  • Daniel P. Gallagher, Jr.Director
  • L. Gerald TarantinoDirector
  • Gregory T. HebrankDirector
  • Paul L. KornblithDirector
Offering amount
$1M
Amount sold
$710K
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$353KraisedJul 2016 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric T. AhrensDirector
  • L. Gerald TarantinoDirector
  • Daniel P. Gallagher, Jr.Director
  • Charles F. O'Hanlon, IIIExecutive Officer, Director
  • Lourdes M. CastellanosExecutive Officer
  • Gregory T. HebrankDirector
  • Thomas Petzinger, Jr.Director
  • Paul L. KornblithDirector
Offering amount
$353K
Amount sold
$353K
Minimum investment
$5K
Proceeds to insiders
$60K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$175KraisedSep 2014 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel P. Gallagher, Jr.Director
  • L. Gerald TarantinoDirector
  • Eric T. AhernsDirector
  • Paul L. KornblithDirector
  • Thomas Petzinger, Jr.Director
  • Lourdes M. CastellanosExecutive Officer
  • Charles F. O'Hanlon, IIIExecutive Officer, Director
Offering amount
$1M
Amount sold
$175K
Minimum investment
$5K
Proceeds to insiders
$100K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$267.5KraisedSep 2014 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel P GallagherDirector
  • Paul L KornblithDirector
  • Charles F O'HanlonExecutive Officer, Director
  • Eric AhrensDirector
  • Thomas PetzingerDirector
  • L Gerald TarantinoDirector
  • Lourdes M CastellanosExecutive Officer
  • Gregory T HebrankDirector
Offering amount
$1M
Amount sold
$267.5K
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$125KraisedFeb 2012 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • L. Gerald TarantinoDirector
  • Daniel P. Gallagher, Jr.Director
  • T. Ronald CasperExecutive Officer
  • Ronald B. HerbermanDirector
  • Thomas Petzinger, Jr.Director
  • Charles F. O'Hanlon, IIIExecutive Officer, Director
  • Eric T. AhernsDirector
  • Paul L. KornblithDirector
  • Kevin S. McClatchyDirector
Offering amount
$1.3M
Amount sold
$125K
Minimum investment
$5K
First sale
Feb 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 7 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2020$224.8K
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$340.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$169.3K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2012$379.2K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2009$132.3K
National Institutes of Health (NIH)National Institutes of HealthPhase I2008$273K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has Celsense raised?
Celsense has disclosed $1.8M raised across 6 of its 7 known rounds.
Where is Celsense headquartered?
Celsense is headquartered in Pittsburgh, US.